Correlation Between OncoCyte Corp and Enzo Biochem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Enzo Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Enzo Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Enzo Biochem, you can compare the effects of market volatilities on OncoCyte Corp and Enzo Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Enzo Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Enzo Biochem.

Diversification Opportunities for OncoCyte Corp and Enzo Biochem

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between OncoCyte and Enzo is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Enzo Biochem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzo Biochem and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Enzo Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzo Biochem has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Enzo Biochem go up and down completely randomly.

Pair Corralation between OncoCyte Corp and Enzo Biochem

Considering the 90-day investment horizon OncoCyte Corp is expected to under-perform the Enzo Biochem. In addition to that, OncoCyte Corp is 1.16 times more volatile than Enzo Biochem. It trades about -0.01 of its total potential returns per unit of risk. Enzo Biochem is currently generating about 0.0 per unit of volatility. If you would invest  172.00  in Enzo Biochem on August 25, 2024 and sell it today you would lose (75.00) from holding Enzo Biochem or give up 43.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

OncoCyte Corp  vs.  Enzo Biochem

 Performance 
       Timeline  
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Enzo Biochem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

OncoCyte Corp and Enzo Biochem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoCyte Corp and Enzo Biochem

The main advantage of trading using opposite OncoCyte Corp and Enzo Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Enzo Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzo Biochem will offset losses from the drop in Enzo Biochem's long position.
The idea behind OncoCyte Corp and Enzo Biochem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets